The Francis Crick Institute
Browse

Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC).

Download (3.19 MB)
journal contribution
posted on 2024-11-18, 14:49 authored by Liani G Devito, Eugénie S Lim, Samuel M O'Toole, Scott TC Shepherd, Daqi Deng, Hugang Feng, Taja Barber, William M Drake, Samra Turajlic, Lyn Healy
VHL disease is an inherited and autosomal dominant disorder affecting 1 in 36,0000 individuals worldwide. It is caused by von Hippel-Lindau (VHL) gene mutations and can affect both genders and all ethnic backgrounds (Nordstrom-O'Brien et al., 2009; Maher, 2004). Here, we generated and characterised two iPSC lines derived from patients with histopathologically confirmed clear cell renal cell carcinoma (ccRCC) and VHL Type 1 enrolled in the TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)). PBMCs were reprogrammed to pluripotency using a genome non-integrating Sendai virus (SeV) vectors protocol. Both human iPSC lines displayed normal morphology, expressed markers associated with stemness and differentiated into the three germ layers. The iPSC lines could be used as a disease-specific cellular model to understand furtherthe inherited disorder of Type 1 von Hippel-Lindau (VHL) disease.

Funding

Crick (Grant ID: CC2044, Grant title: Turajlic CC2044) Crick (Grant ID: CC1070, Grant title: STP HESCU)

History

Usage metrics

    The Francis Crick Institute

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC